Androgen receptor in bladder cancer: A promising therapeutic target
There has been a significant progress in the treatment of metastatic urothelial carcinoma in the last few years with the advent of immunotherapy after a long gap of no drug approvals for over 4 decades. While immunotherapy with checkpoint inhibitors has revolutionized the treatment of urothelial car...
Saved in:
| Main Authors: | Abhishek Tripathi, Shilpa Gupta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | Asian Journal of Urology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388220300370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aggressive Bladder Urothelial Carcinoma in an HIV‐Positive Male With Neurogenic Bladder Dysfunction due to Spina Bifida: An Autopsy Case
by: Masahiro Ueno, et al.
Published: (2025-05-01) -
Precision targeting of androgen receptor–ferroptosis crosstalk in prostate cancer: From mechanisms to therapeutic strategies
by: Dongfang Lv, et al.
Published: (2025-09-01) -
ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01) -
Correction: ELOVL2 mediated stabilization of AR contributes to enzalutamide resistance in prostate cancer
by: Jinpeng Cen, et al.
Published: (2025-06-01) -
YAP‐TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape
by: Roberto Alva‐Ruiz, et al.
Published: (2024-11-01)